Yang L, Li X (2020) Evaluation of Corneal Transparency in Diabetic Patients Aged 60 Years and Over. Int J Diabetes Clin Res 7:119.

Original Article | OPEN ACCESS DOI: 10.23937/2377-3634/1410119

Evaluation of Corneal Transparency in Diabetic Patients Aged 60 Years and Over

Luling Yang and Xuemin Li*

Department of Ophthalmology, Peking University Third Hospital, Beijing, China



The aim of the study was to retrospectively evaluate the changes of corneal transparency in diabetic patients across 3 different age groups.

Materials and methods

We enrolled 135 diabetes mellitus (DM) patients and 154 control subjects in this retrospective and nonrandomized study. Corneal backward light scattering information was collected from different corneal layers and annuli by using Scheimpflug tomography (Pentacam HR).


The corneal densitometry analysis results varied between different age groups. In the 60 to 69 age group, the anterior layer at zone 0 to 2 mm had better corneal clarity in controls than in DM patients. Corneal densitometry values were markedly higher in diabetic eyes compared with control eyes in 70 to 79 age group when considered by central zones of total cornea at the 2 to 6 mm. The corneal transparency increased in 80 to 89 years DM patients in the majority of corneal zones. Besides, a weak correlation was found between the occurrence of DM and corneal densitometry at 0 to 2 mm and 2 to 6 mm concentric radial zones in anterior, posterior and total corneal depth.


Diabetic patients showed higher values of corneal densitometry especially in central annuli in anterior layer than controls aged 60 years and over. Corneal transparency decreases differently in DM eyes across 3 age groups.


Corneal backward light scattering, Corneal densitometry, Corneal transparency, Diabetes mellitus, Pentacam scheimpflug system


Diabetes mellitus is known as a 21st century challenge [1] and diabetes is a systemic disease that could even affect both the anterior and posterior segments of the eye. Besides diabetic retinopathy, corneal epithelium, stroma, and endothelium also change in diabetic patients. Precious studies have shown disruption of epithelial barrier function [2,3], increased polymegathism and polymorphism of endothelial cells [4,5], low density of endothelial cells [6], production and accumulation of advanced glycation end products [7], etc. in the eyes of diabetic patients. These alterations on the cornea could lead to decrease corneal transparency and increase corneal backward light scattering.

Healthy cornea ideally does not absorb visible light and the light that it scatters is minimal [8,9]. Loss of the transmission of light through the cornea give rise to the increasement of cornea backward light scattering. Past researches have verified that corneal densitometry, which describes the level of corneal transparency, could be used as a tool to evaluate corneal health and detect subclinical keratoconus [10,11]. Corneal densitometry also provides objective and quantitative information about corneal backscatter after corneal collagen crosslinking, refractive surgery, cataract surgery, keratoplasty, etc. [12-16], which is helpful for doctors to study the effects on the post-operating recovery of patients.

The Pentacam HR (Oculus, Wetzlar, Germany) employs a rotating Scheimpflug camera to image the anterior segment of the ocular tissues noninvasively and sequentially. The procedure of densitometry analysis measures corneal transparency by backscattered light and applies grayscale units as outputs. The system also provides precise data to describe the degree of corneal clarity at specific zones, allowing us to know the change in value.

The purpose of our study was to evaluate the changes of corneal transparency in diabetic patients aged 60 years and over. We also investigate the differences of corneal densitometry between people with diabetic of different age groups.


We retrospectively reviewed the preoperative data of cataract patients who had undergone cataract surgery between august 2019 and November 2019 at Peking University Third Hospital. Only patients who were aged more than 60 years and had no history of ocular surgery were enrolled in our research. Eyes with any ocular diseases such as corneal infections, corneal dystrophies, uveitis and nystagmus, etc. were excluded. Patients who were not able to fully cooperative for Scheimpflug system examinations were also excluded. Both eyes had undergone routine ophthalmic examinations. As a result, 135 patients with DM and 154 patients without DM met the inclusion criteria. 578 eyes were categorized into 3 age groups (60-69, 70-79, 80-89 age groups).

In order to obtain corneal densitometry data, patients were instructed to take examinations following a series of standardized procedures as recommended in the instruction manual. All measurements were performed in dimness and automatically completed with 25 cross-sectional images in 2 seconds. The densitometry images comprises of 4 concentric radial zones around the corneal apex (the central 0-2, 2-6, 6-10, and 10-12 mm zones) and 3 layers (the anterior 120 μm,the posterior 60 μm and the central corneal layer). The scanning output is expressed in grayscale units (GSU). The GSU level is ranged from 0 (maximum transparency) to 100 (completely opacity), according to the degree of backward light scattering from the cornea. An example of the Scheimpflug optical densitometry output is shown in Figure 1.

Figure 1: An example of the data output for corneal densitometry assessment. View Figure 1

Statistical Analysis

IBM SPSS statistics software package version 24.0 for Windows was used for statistical analysis. Descriptive statistics were presented as the mean ± standard deviations (SD). Normality of data distributions was examined using Kolmogorov-Smirnov test. Student-t test for 2 independent samples was used when parametric analysis was possible and the nonparametric of Mann-Whitney U test was applied when parametric analysis was not possible. The Spearman's bivariate correlation analysis was performed to determine the relationship between the occurrence of DM and corneal densitometry values. The significance level for all of the tests was set at 5%.


This retrospective study included 135 patients with DM and 154 controls (112 Male, 177 Female) that were divided into 3 age groups. The mean age of DM patients was 72.71 with SD 8.15. The controls' mean age was 72.69 with a SD of 7.67 and there was no significant difference in mean age between 3 age groups. The demographics of the subjects are summarized Table 1.

Table 1: Demographics of the subjects. View Table 1

The mean corneal densitometry results are summarized in Table 2. The corneal densitometry analysis results varied between different age groups. In the 60 to 69 age group, the anterior layer at zone 0 to 2 mm has better corneal clarity in controls than in DM patients while corneal densitometry in other zones shows no significant difference. In corneal central zones of 2 to 6 mm, corneal densitometry values were markedly higher in diabetic eyes compared with control eyes in 70 to 79 age group in full depth. The corneal transparency increased in 80 to 89 years DM patients in specific corneal zones including the anterior layer at 0 to 2 mm and 2 to 6 mm, the central layer at 0 to 2 mm, 2 to 6 mm, 10 to 12 mm and 0 to 12 mm and the posterior layer at 0 to 2 mm and 10 to 12 mm regions. Moreover, the total light backscatter at total corneal thickness was higher at 0 to 2 mm, 2 to 6 mm, 10 to 12 mm and 0 to 12 mm concentric radial zones. A weak correlation was found between the occurrence of DM and corneal densitometry at 0 to 2 mm and 2 to 6 mm corneal zones in anterior, posterior and total corneal depth. The correlation coefficients between the occurrence of DM and corneal densitometry are given in Table 3.

Table 2: Scheimpflug Measurements in Layers and Concentric Radial Zones of Diabetic and Control Eyes. View Table 2

Table 3: Spearman correlation between the occurrence of diabetes mellitus and corneal densitometry. View Table 3


This study demonstrated that corneal densitometry increases in DM eyes in different age groups and the affected area tends to expand with age. A previous research revealed a significant increase in corneal densitometry in the 0 to 10 mm zone of the anterior layer and 0 to 2 mm zone of the total cornea in diabetic eyes versus the eyes of controls aged 40 to 60 [17]. A pilot study collected corneal backscatter in seven meridians for each eye, with orientations ranging from 70° to 110° and concluded that the corneal backscatter in corneal 3 mm and 5 mm central zones of insulin-dependent and non-insulin-dependent DM patients was higher than that of controls [18]. Whereas, there was no statistically significant difference in corneal clarity between children with type 1 DM and control subjects [19]. The intraocular straylight level in pseudophakic eyes was higher in diabetic patients than in nondiabetic patients and had a tendency to increase as the severity of diabetic retinopathy increased [20]. We speculated that the difference of population samples causes the different outcomes.

In the present study, corneal backscattering of different layers in many zones in diabetic eyes was markedly higher than in controls' eyes aged 70 and over. Previous studies revealed that diabetic patients seemed to have thicker corneas, less cell density and hexagonality, and more irregular cell size of the corneal endothelium cells than those of the controls [4-6]. Abnormal morphology of the corneal endothelial cells combined with increased central corneal thickness is an indicator of alterations of endothelial pump function, which decrease corneal transparency [5]. Moreover, Anbar, et al. [21] and Islam, et al. [22] found a significant correlation between the duration of diabetes and polymegathism and polymorphism of corneal endothelium cells, supporting the idea that the longer the disease evolution, the higher endothelial loss. As these changes in corneal endothelial cells are age-related, corneal densitometry in the posterior layer also increases with age in all concentric radial zones [23,24].

The results additionally revealed that corneal backscatter increased to various extents in DM eyes in the 0 to 2 mm circular zone in different age groups and the evolution of DM could possibly increase the corneal densitometry at 0 to 2 mm and 2 to 6 mm in anterior, central and total corneal depth. The visual effect of increased corneal densitometry at pupillary zone is not clear. Prior researches showed intraocular scattering increased in the diabetic eyes compared with controls and the level of intraocular straylight had a tendency to increase as the severity of diabetic retinopathy increased [20,21]. Besides, optical quality of the diabetic eyes was reduced simultaneously in comparison with the control group [21]. There is not a precise relation between the level of backward light scattering and the level of forward light scattering in the cornea [9]. More investigations should be focused on the level of corneal backscatter and its effect on visual quality in clear cornea of diabetic patients.

We also observed a weak correlation between corneal densitometry and the occurrence of DM at 0 to 2 mm and 2 to 6 mm in anterior, posterior and total corneal depth in all patients we enrolled. The speculation may be concluded that the anterior layer was the most susceptible layer in cornea under hyperglycemia and the corneal backward light scattering of the anterior layer increased in DM patients in the same age group. As defined with corneal densitometry software, the anterior layer corresponds to corneal epithelial and anterior stromal. Loss of the subbasal nerve plexus, corneal epithelial thinning and a reduction in basal epithelial cell density was determined using In vivo confocal microscopy in type I diabetic rats [2,3]. Alterations of corneal subbasal plexus was also found in patients with type I diabetes [21]. Production and accumulation of advanced glycation end products leads to the morphological disorders including increase of membrane thickness and multilamination [22]. A series of proteins of epithelial basement membrane such as laminin-l, entactin/nidogen and laminin-10 also change in DM eyes [23,24]. In addition, DM is associated with increased collagen crosslinking mediated by glycated proteins in situ [25,26]. These alterations may account for the increase of corneal densitometry in corneal anterior layer. And a recent research showed a loss in corneal keratocyte density is associated with corneal sub-basal plexus nerve damage in patients with and without diabetic neuropathy by using corneal confocal microscopy [27]. Corneal confocal microscopy has been recognized as one potentially useful method for diagnosing diabetic peripheral neuropathy [28]. We believe corneal densitometry using Scheimpflug system may also provide a method of diabetic peripheral neuropathy in early screening, diagnosis and intervention.

It is worth noting that the obvious rise of corneal densitometry at 6 to 10 mm and 10 to 12 mm concentric radial zones may have low clinical significance in the same age group. As the possible existence of marginal corneal degenerations (influenced by environmental and genetic factors) such as cornea arcus senilis and white limbus girdle of Vogt [29] cannot be ignored, corneal densitometry value of peripheral cornea at 6 to 10 mm is certainly high. Because of natural variability in total corneal diameter [30], the 10 to 12 mm concentric radial zones is possibly part of the limbus or sclera, resulting to high level of corneal backward light scattering. Due to these factors, the increase in corneal backscatter at 6 to 10 mm and 10 to 12 mm region cannot be definitively attributed to the duration of DM.


The current study had numerous limitations. We did not distinguish the type of diabetes as all subjects aged 60 years and over. Another limitation is that the diabetic retinopathy stages were not taken into account. It is generally known that three major risk factors for diabetic retinopathy are diabetes duration, hemoglobin A1c (HbA1c) and blood pressure [31]. Further studies are needed to investigate all the interaction between these above-mentioned factors and corneal densitometry in patients with DM.


In summary, corneal densitometry provides a beneficial means for quantitative evaluation of the corneal transparency. As results shows, corneal densitometry is higher especially in central annuli in anterior layer in DM eyes when compared with controls aged 60 years and over. Moreover, corneal transparency decreases to various extents in DM eyes in different age groups and the affected region tends to expand with age.


Financial support for this research was provided by National Science and Technology Major Project (2018ZX10101004).


  1. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: A 21st century challenge. Lancet Diabetes Endocrinol 2: 56-64.
  2. Yin J, Huang J, Chen C, Gao N, Wang F, et al. (2011) Corneal complications in streptozocin-induced type I diabetic rats. Invest Ophthalmol Vis Sci 52: 6589-6596.
  3. Cai D, Zhu M, Petroll WM, Koppaka V, Robertson DM (2014) The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am J Pathol 184: 2662-2670.
  4. Storr-Paulsen A, Singh A, Jeppesen H, Norregaard JC, Thulesen J (2014) Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol 92: 158-160.
  5. Lee JS, Oum BS, Choi HY, Lee JE, Cho BM (2006) Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye (Lond) 20: 315-318.
  6. Chocron IM, Rai DK, Kwon JW, Bernstein N, Hu J, et al. (2018) Effect of diabetes mellitus and metformin on central corneal endothelial cell density in eye bank eyes. Cornea 37: 964-966.
  7. Shi L, Yu X, Yang H, Wu X (2013) Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. PLoS One 8: e66781.
  8. Meek KM, Knupp C (2015) Corneal structure and transparency. Prog Retin Eye Res 49: 1-16.
  9. Spadea L, Maraone G, Verboschi F, Vingolo EM, Tognetto D (2016) Effect of corneal light scatter on vision: A review of the literature. Int J Ophthalmol 9: 459-464.
  10. Otri AM, Fares U, Al-Aqaba MA, Dua HS (2012) Corneal densitometry as an indicator of corneal health. Ophthalmology 119: 501-508.
  11. Koc M, Tekin K, Tekin MI, Uzel MM, Kosekahya P, et al. (2018) An early finding of keratoconus: Increase in corneal densitometry. Cornea 37: 580-586.
  12. Alnawaiseh M, Zumhagen L, Zumhagen S, Schulte L, Rosentreter A, et al. (2016) Corneal densitometry as a novel technique for monitoring amiodarone therapy. Ophthalmology 123: 2294-2299.
  13. Rehnman JB, Lindén C, Hallberg P, Behndig A (2015) Treatment effect and corneal light scattering with 2 corneal cross-linking protocols: A randomized clinical trial. JAMA ophthalmol 133: 1254-1260.
  14. Savini G, Huang J, Lombardo M, Serrao S, Schiano-Lomoriello D, et al. (2016) Objective monitoring of corneal backward light scattering after femtosecond laser-assisted LASIK. J Refract Surg 32: 20-25.
  15. Schaub F, Enders P, Bluhm C, Bachmann BO, Cursiefen C, et al. (2017) Two-year course of corneal densitometry after descemet membrane endothelial keratoplasty. Am J Ophthalmol 175: 60-67.
  16. Zukaite I, Bedi KK, Ali S, Nanavaty MA (2019) Influence of peripheral corneal relaxing incisions during cataract surgery for corneal astigmatism up to 2.5 dioptres on corneal densitometry. Eye (Lond) 33: 804-811.
  17. Özyol P, Özyol E (2018) Assessment of corneal backward light scattering in diabetic patients. Eye Contact Lens 44: S92-S96.
  18. Calvo-Maroto AM, Pérez-Cambrodí RJ, Esteve-Taboada JJ, García-Lázaro S, Cerviño AN (2017) Corneal backscatter in insulin-dependent and non-insulin-dependent diabetes mellitus patients: A pilot study. Arq Bras Oftalmol 80: 148-153.
  19. Tekin K, Inanc M, Kurnaz E, Bayramoglu E, Aydemir E, et al. (2017) Objective evaluation of corneal and lens clarity in children with type 1 diabetes mellitus. Am J Ophthalmol 179: 190-197.
  20. Hwang HB, Yim HB, Chung SK (2015) Effect of diabetic retinopathy and diabetes on the intraocular straylight in pseudophakic eyes. BMC Ophthalmol 15: 130.
  21. Schiano Lomoriello D, Abicca I, Parravano M, Giannini D, Russo B, et al. (2019) Early alterations of corneal subbasal plexus in uncomplicated type 1 diabetes patients. J Ophthalmol 2019: 9818217.
  22. Taylor HR, Kimsey RA (1981) Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci 20: 548-553.
  23. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, et al. (1996) Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 44: 1469-1479.
  24. Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, et al. (1998) Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 46: 1033-1041.
  25. Seiler T, Huhle S, Spoerl E, Kunath H (2000) Manifest diabetes and keratoconus: A retrospective case-control study. Graefes Arch Clin Exp Ophthalmol 238: 822-825.
  26. McKay TB, Priyadarsini S, Karamichos D (2019) Mechanisms of collagen crosslinking in diabetes and keratoconus. Cells 8: E1239.
  27. Kalteniece A, Ferdousi M, Azmi S, Marshall A, Soran H, et al. (2018) Keratocyte density is reduced and related to corneal nerve damage in diabetic neuropathy. Invest Ophthalmol Vis Sci 59: 3584-3590.
  28. Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, et al. (2019) Diabetic peripheral neuropathy: Advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol 7: 938-948.
  29. Faragher RG, Mulholland B, Tuft SJ, Sandeman S, Khaw PT (1997) Aging and the cornea. Br J Ophthalmol 81: 814-817.
  30. Cakmak HB, Cagil N, Simavli H, Raza S (2012) Corneal white-to-white distance and mesopic pupil diameter. Int J Ophthalmol 5: 505-509.
  31. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, et al. (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35: 556-564.


Yang L, Li X (2020) Evaluation of Corneal Transparency in Diabetic Patients Aged 60 Years and Over. Int J Diabetes Clin Res 7:119.